April 27, 2024

• 

[THE INVESTOR] Samsung BioLogics has won the best Asia contract manufacturing organization award at the Asia-Pacific Bioprocessing Excellence Awards 2017 held in Singapore, in recognition of its innovation achievements, the company said on Feb. 15.

“By utilizing the latest world-class facilities to both maximize production efficiency and strive for continuous innovation to manufacture high quality biologics with competitive price, Samsung aims to provide the best contract manufacturing service in the world,” the firm said in a press release. 

The Asia-Pacific Bioprocessing Excellence Awards aims to recognize industry’s best practices and innovations that facilitate bio-manufacturing excellence at enhanced speed, reduced cost and superior quality in Asia, in which bio-industry is currently undergoing rapid growth.

The award was held on the sidelines of the 4th Biologics Manufacturing 2017 conference, organized by IMAPAC, a social enterprise headquartered in Singapore.

Some 50 biologic companies from Korea, Singapore, China, Taiwan, Japan and India attended the conference, according to the organizers.

The biologics industry in Asia-Pacific region is the fastest growing market in the world. Asia-Pacific alone accounts for 30 percent of the global biosimilar market.

By Park Han-na (hnpark@heraldcorp.com)